Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Sustained Release of Hydrogen Sulfide (H2S) from Poly(Lactic Acid) Functionalized 4-Hydroxythiobenzamide Microparticles to Protect Against Oxidative Damage.

Do AV, Smith R, Tobias P, Carlsen D, Pham E, Bowden NB, Salem AK.

Ann Biomed Eng. 2019 May 28. doi: 10.1007/s10439-019-02270-9. [Epub ahead of print]

PMID:
31139973
2.

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid.

Miller S, Naccache SN, Samayoa E, Messacar K, Arevalo S, Federman S, Stryke D, Pham E, Fung B, Bolosky WJ, Ingebrigtsen D, Lorizio W, Paff SM, Leake JA, Pesano R, DeBiasi R, Dominguez S, Chiu CY.

Genome Res. 2019 May;29(5):831-842. doi: 10.1101/gr.238170.118. Epub 2019 Apr 16.

3.

Assessment of the Clinical Benefit of Imaging in Children With Unilateral Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Ropers FG, Pham ENB, Kant SG, Rotteveel LJC, Rings EHHM, Verbist BM, Dekkers OM.

JAMA Otolaryngol Head Neck Surg. 2019 Apr 4. doi: 10.1001/jamaoto.2019.0121. [Epub ahead of print]

PMID:
30946449
4.

A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression.

Myers LM, Tal MC, Torrez Dulgeroff LB, Carmody AB, Messer RJ, Gulati G, Yiu YY, Staron MM, Angel CL, Sinha R, Markovic M, Pham EA, Fram B, Ahmed A, Newman AM, Glenn JS, Davis MM, Kaech SM, Weissman IL, Hasenkrug KJ.

Nat Commun. 2019 Feb 15;10(1):794. doi: 10.1038/s41467-019-08637-9.

5.

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease.

Wu FTH, Xu P, Chow A, Man S, Krüger J, Khan KA, Paez-Ribes M, Pham E, Kerbel RS.

Br J Cancer. 2019 Jan;120(2):196-206. doi: 10.1038/s41416-018-0297-1. Epub 2018 Nov 30.

PMID:
30498230
6.

Dental Student to Patient Communication Analysis: A Pilot Study.

Bowles K, Sehgal HS, Santelmann L, Pham EP, Kohli R.

Health Commun. 2018 Oct 25:1-8. doi: 10.1080/10410236.2018.1536953. [Epub ahead of print]

PMID:
30358413
7.

Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry.

Chen Z, Detvo ST, Pham E, Gassensmith JJ.

J Vis Exp. 2018 May 27;(135). doi: 10.3791/57712.

PMID:
29889200
8.

ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.

Bado I, Pham E, Soibam B, Nikolos F, Gustafsson JÅ, Thomas C.

Oncotarget. 2018 Apr 27;9(32):22509-22522. doi: 10.18632/oncotarget.25147. eCollection 2018 Apr 27.

9.

Investigation of mixed model repeated measures analyses and non-linear random coefficient models in the context of long-term efficacy data.

Delafont B, Carroll K, Vilain C, Pham E.

Pharm Stat. 2018 Sep;17(5):515-526. doi: 10.1002/pst.1868. Epub 2018 May 20.

PMID:
29781237
10.

A mouse model of autism implicates endosome pH in the regulation of presynaptic calcium entry.

Ullman JC, Yang J, Sullivan M, Bendor J, Levy J, Pham E, Silm K, Seifikar H, Sohal VS, Nicoll RA, Edwards RH.

Nat Commun. 2018 Jan 23;9(1):330. doi: 10.1038/s41467-017-02716-5.

11.

Synthetically lethal nanoparticles for treatment of endometrial cancer.

Ebeid K, Meng X, Thiel KW, Do AV, Geary SM, Morris AS, Pham EL, Wongrakpanich A, Chhonker YS, Murry DJ, Leslie KK, Salem AK.

Nat Nanotechnol. 2018 Jan;13(1):72-81. doi: 10.1038/s41565-017-0009-7. Epub 2017 Dec 4.

12.

Screening for attention-deficit/hyperactivity disorder in borderline personality disorder.

Weibel S, Nicastro R, Prada P, Cole P, Rüfenacht E, Pham E, Dayer A, Perroud N.

J Affect Disord. 2018 Jan 15;226:85-91. doi: 10.1016/j.jad.2017.09.027. Epub 2017 Sep 23.

PMID:
28964997
13.

Insomnia in adult attention-deficit/hyperactivity disorder: A comparison with borderline personality disorder population in a clinical setting and control participants.

Weibel S, Jermann F, Weiner L, Nicastro R, Ardu S, Pham E, Hasler R, Dayer A, Prada P, Perroud N.

Compr Psychiatry. 2017 Jul;76:119-128. doi: 10.1016/j.comppsych.2017.04.009. Epub 2017 May 5.

PMID:
28501733
14.

Sensory defects and developmental delay among children with congenital rubella syndrome.

Toizumi M, Nguyen GT, Motomura H, Nguyen TH, Pham E, Kaneko KI, Uematsu M, Nguyen HA, Dang DA, Hashizume M, Yoshida LM, Moriuchi H.

Sci Rep. 2017 Apr 13;7:46483. doi: 10.1038/srep46483.

15.

Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.

Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P.

Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):731-741. doi: 10.1002/pds.4169. Epub 2017 Feb 7. Review.

PMID:
28176407
16.

Neurobrucellosis: Unexpected Answer From Metagenomic Next-Generation Sequencing.

Mongkolrattanothai K, Naccache SN, Bender JM, Samayoa E, Pham E, Yu G, Dien Bard J, Miller S, Aldrovandi G, Chiu CY.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):393-398. doi: 10.1093/jpids/piw066.

17.

Future Therapy for Hepatitis B Virus: Role of Immunomodulators.

Pham EA, Perumpail RB, Fram BJ, Glenn JS, Ahmed A, Gish RG.

Curr Hepatol Rep. 2016;15(4):237-244. Epub 2016 Nov 10. Review.

18.

Both the anti- and pro-apoptotic functions of villin regulate cell turnover and intestinal homeostasis.

Wang Y, George SP, Roy S, Pham E, Esmaeilniakooshkghazi A, Khurana S.

Sci Rep. 2016 Oct 21;6:35491. doi: 10.1038/srep35491.

19.

Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.

Poewe W, Burbaud P, Castelnovo G, Jost WH, Ceballos-Baumann AO, Banach M, Potulska-Chromik A, Ferreira JJ, Bihari K, Ehler E, Bares M, Dzyak LA, Belova AN, Pham E, Liu WJ, Picaut P.

Mov Disord. 2016 Nov;31(11):1649-1657. doi: 10.1002/mds.26760. Epub 2016 Sep 21.

PMID:
27653448
20.

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy.

Shaked Y, Pham E, Hariharan S, Magidey K, Beyar-Katz O, Xu P, Man S, Wu FT, Miller V, Andrews D, Kerbel RS.

Cancer Res. 2016 Oct 15;76(20):5983-5993. Epub 2016 Aug 28.

21.

Reconstitution and Functional Analysis of a Full-Length Hepatitis C Virus NS5B Polymerase on a Supported Lipid Bilayer.

Cho NJ, Pham EA, Hagey RJ, Lévêque VJ, Ma H, Klumpp K, Glenn JS.

ACS Cent Sci. 2016 Jul 27;2(7):456-66. doi: 10.1021/acscentsci.6b00112. Epub 2016 Jun 13.

22.

Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges.

Cholankeril G, Perumpail RB, Pham EA, Ahmed A, Harrison SA.

Hepatology. 2016 Sep;64(3):954. doi: 10.1002/hep.28719. Epub 2016 Aug 2. No abstract available.

PMID:
27388553
23.

cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection.

Lio CW, McDonald B, Takahashi M, Dhanwani R, Sharma N, Huang J, Pham E, Benedict CA, Sharma S.

J Virol. 2016 Aug 12;90(17):7789-97. doi: 10.1128/JVI.01040-16. Print 2016 Sep 1.

24.

Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer.

Pham E, Yin M, Peters CG, Lee CR, Brown D, Xu P, Man S, Jayaraman L, Rohde E, Chow A, Lazarus D, Eliasof S, Foster FS, Kerbel RS.

Cancer Res. 2016 Aug 1;76(15):4493-503. doi: 10.1158/0008-5472.CAN-15-3435. Epub 2016 Jun 20.

25.

Association of RSV-A ON1 genotype with Increased Pediatric Acute Lower Respiratory Tract Infection in Vietnam.

Yoshihara K, Le MN, Okamoto M, Wadagni AC, Nguyen HA, Toizumi M, Pham E, Suzuki M, Nguyen AT, Oshitani H, Ariyoshi K, Moriuchi H, Hashizume M, Dang DA, Yoshida LM.

Sci Rep. 2016 Jun 16;6:27856. doi: 10.1038/srep27856.

26.

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.

Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H, McGuire MH, Haemmerle M, Vidal-Anaya V, Olsen C, Rodriguez-Aguayo C, Filant J, Ehsanipour EA, Herbrich SM, Maiti SN, Huang L, Kim JH, Zhang X, Han HD, Armaiz-Pena GN, Seviour EG, Tucker S, Zhang M, Yang D, Cooper LJ, Ali-Fehmi R, Bar-Eli M, Lee JS, Ram PT, Baggerly KA, Lopez-Berestein G, Hung MC, Sood AK.

Nat Commun. 2016 Apr 4;7:11169. doi: 10.1038/ncomms11169.

27.

AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.

Delgado MR, Tilton A, Russman B, Benavides O, Bonikowski M, Carranza J, Dabrowski E, Dursun N, Gormley M, Jozwiak M, Matthews D, Maciag-Tymecka I, Unlu E, Pham E, Tse A, Picaut P.

Pediatrics. 2016 Feb;137(2):e20152830. doi: 10.1542/peds.2015-2830. Epub 2016 Jan 26.

28.

By moonlighting in the nucleus, villin regulates epithelial plasticity.

Patnaik S, George SP, Pham E, Roy S, Singh K, Mariadason JM, Khurana S.

Mol Biol Cell. 2016 Feb 1;27(3):535-48. doi: 10.1091/mbc.E15-06-0453. Epub 2015 Dec 10.

29.

Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas.

Jayasekera CR, Perumpail RB, Chao DT, Pham EA, Aggarwal A, Wong RJ, Ahmed A.

Dig Dis Sci. 2015 Dec;60(12):3552-7.

PMID:
26467703
30.

A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.

Perumpail RB, Wong RJ, Pham EA, Higgins JP, Daugherty TJ, Ahmed A.

Dig Dis Sci. 2016 Jan;61(1):39-41. doi: 10.1007/s10620-015-3756-z. Epub 2015 Jun 17. No abstract available.

PMID:
26082077
31.

ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Humtsoe JO, Pham E, Louie RJ, Chan DA, Kramer RH.

Oncogene. 2016 Mar 24;35(12):1554-64. doi: 10.1038/onc.2015.220. Epub 2015 Jun 15.

PMID:
26073080
32.

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.

Perumpail RB, Wong RJ, Ha LD, Pham EA, Wang U, Luong H, Kumari R, Daugherty TJ, Higgins JP, Younossi ZM, Kim WR, Glenn JS, Ahmed A.

Transpl Infect Dis. 2015 Apr;17(2):275-8. doi: 10.1111/tid.12348. Epub 2015 Jan 31.

PMID:
25641426
33.

Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.

Pham E, Birrer MJ, Eliasof S, Garmey EG, Lazarus D, Lee CR, Man S, Matulonis UA, Peters CG, Xu P, Krasner C, Kerbel RS.

Clin Cancer Res. 2015 Feb 15;21(4):808-18. doi: 10.1158/1078-0432.CCR-14-2810. Epub 2014 Dec 18.

34.

Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome.

Cho NJ, Lee C, Pang PS, Pham EA, Fram B, Nguyen K, Xiong A, Sklan EH, Elazar M, Koytak ES, Kersten C, Kanazawa KK, Frank CW, Glenn JS.

Gastroenterology. 2015 Mar;148(3):616-25. doi: 10.1053/j.gastro.2014.11.043. Epub 2014 Dec 2.

35.

Angiogenic gene therapy does not cause retinal pathology.

Prokosch V, Stupp T, Spaniol K, Pham E, Nikol S.

J Gene Med. 2014 Sep-Oct;16(9-10):309-16. doi: 10.1002/jgm.2806.

PMID:
25322754
36.

Mortality associated with pulmonary hypertension in congenital rubella syndrome.

Toizumi M, Motomura H, Vo HM, Takahashi K, Pham E, Nguyen HA, Le TH, Hashizume M, Ariyoshi K, Dang DA, Moriuchi H, Yoshida LM.

Pediatrics. 2014 Aug;134(2):e519-26. doi: 10.1542/peds.2013-4184. Epub 2014 Jul 7.

37.

Engineered networks of synthetic and natural proteins to control cell migration.

Mills E, Pham E, Nagaraj S, Truong K.

ACS Synth Biol. 2012 Jun 15;1(6):211-20. doi: 10.1021/sb3000172. Epub 2012 May 4.

PMID:
23651204
38.

TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.

Bender A, Desplats P, Spencer B, Rockenstein E, Adame A, Elstner M, Laub C, Mueller S, Koob AO, Mante M, Pham E, Klopstock T, Masliah E.

PLoS One. 2013 Apr 23;8(4):e62277. doi: 10.1371/journal.pone.0062277. Print 2013.

39.

Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study.

Clayton P, Bonnemaire M, Dutailly P, Maisonobe P, Naudin L, Pham E, Zhang Z, Grupe A, Thiagalingam A, Denèfle P; EPIGROW Study Group.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1122-30. doi: 10.1210/jc.2012-4283. Epub 2013 Apr 17. Erratum in: J Clin Endocrinol Metab. 2014 Jun;99(6):2315. multiple investigator names added. J Clin Endocrinol Metab. 2013 Oct;98(10):4213. Martos-Moren, Gabriel Á [corrected to Martos-Moreno, Gabriel Á]. J Clin Endocrinol Metab. 2014 Jul;99(7):2619. Gazzarotti, Laura [corrected to Guazzarotti, Laura; Cherubini, Valerio [corrected to Cherubini, Valentino].

PMID:
23596138
40.

Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction.

Nishimura T, Hu Y, Wu M, Pham E, Suemizu H, Elazar M, Liu M, Idilman R, Yurdaydin C, Angus P, Stedman C, Murphy B, Glenn J, Nakamura M, Nomura T, Chen Y, Zheng M, Fitch WL, Peltz G.

J Pharmacol Exp Ther. 2013 Feb;344(2):388-96. doi: 10.1124/jpet.112.198697. Epub 2012 Nov 8. Erratum in: J Pharmacol Exp Ther. 2013 May;345(2):327. Nishimura, Toshiko [corrected to Nishimura, Toshihiko].

41.

Revisiting epithelial-to-mesenchymal transition through adenoid cystic carcinoma.

Siu A, Lee C, Pham E, Ramos DM.

Anticancer Res. 2012 Sep;32(9):3683-8. Erratum in: Anticancer Res. 2012 Nov;32(11):5137.

PMID:
22993306
42.

The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB/IV non-small cell lung carcinoma.

Higginson DS, Chen RC, Tracton G, Morris DE, Halle J, Rosenman JG, Stefanescu M, Pham E, Socinski MA, Marks LB.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e385-92. doi: 10.1016/j.ijrobp.2012.04.045. Epub 2012 Aug 1.

PMID:
22857887
43.

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C.

Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23.

44.

Engineered regulation of lysozyme by the SH3-CB1 binding interaction.

Pham E, Truong K.

Protein Eng Des Sel. 2012 Jun;25(6):307-11. doi: 10.1093/protein/gzs020. Epub 2012 Apr 23.

PMID:
22532698
45.

Engineering a photoactivated caspase-7 for rapid induction of apoptosis.

Mills E, Chen X, Pham E, Wong S, Truong K.

ACS Synth Biol. 2012 Mar 16;1(3):75-82. doi: 10.1021/sb200008j. Epub 2011 Nov 4.

PMID:
23651071
46.

Effects of rapamycin-induced oligomerization of parvalbumin, Stim1 and Orai1 in puncta formation.

Pham E, Wong SS, Nagaraj S, Truong K.

Cell Calcium. 2012 May;51(5):418-25. doi: 10.1016/j.ceca.2012.01.007. Epub 2012 Feb 23.

PMID:
22364775
47.

Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity.

Behr-Roussel D, Oger S, Pignol B, Pham E, Le Maux A, Chabrier PE, Caisey S, Compagnie S, Picaut P, Bernabé J, Alexandre L, Giuliano F, Denys P.

Eur Urol. 2012 May;61(5):1054-61. doi: 10.1016/j.eururo.2012.01.051. Epub 2012 Feb 8.

PMID:
22341129
48.

Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells.

Humtsoe JO, Koya E, Pham E, Aramoto T, Zuo J, Ishikawa T, Kramer RH.

Exp Cell Res. 2012 Feb 15;318(4):379-90. doi: 10.1016/j.yexcr.2011.11.011. Epub 2011 Nov 29.

PMID:
22154512
49.

Structural map of a microRNA-122: hepatitis C virus complex.

Pang PS, Pham EA, Elazar M, Patel SG, Eckart MR, Glenn JS.

J Virol. 2012 Jan;86(2):1250-4. doi: 10.1128/JVI.06367-11. Epub 2011 Nov 9.

50.

Simplified RNA secondary structure mapping by automation of SHAPE data analysis.

Pang PS, Elazar M, Pham EA, Glenn JS.

Nucleic Acids Res. 2011 Dec;39(22):e151. doi: 10.1093/nar/gkr773. Epub 2011 Sep 30.

Supplemental Content

Support Center